(MENAFN- GlobeNewsWire - Nasdaq)
NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
La Jolla Pharmaceutical Company (NASDAQ: LJPC)'s sale to Innoviva, Inc. for $6.23 per share in cash. If you are a La Jolla shareholder, click here to learn more about your rights and options .
Euronav NV (NYSE: EURN)'s sale to Frontline Ltd. for 1.45 Frontline shares for every Euronav share. If you are a Euronav shareholder, click here to learn more about your rights and options .
Emclaire Financial Corp. (NASDAQ: EMCF)'s sale to Farmers National Banc Corp. Pursuant to the agreement, Emclaire shareholders may elect to receive either $40.00 per share in cash or 2.15 shares of Farmers' common stock, subject to an overall limitation of 70% of the shares being exchanged for Farmers' shares and 30% for cash. If you are an Emclaire shareholder, click here to learn more about your rights and options .
Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email or .
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
Tags Class Action
MENAFN11072022004107003653ID1104514721
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.